Cas:1062541-77-8 6-Bromo-3-methoxy-2,4-dimethylpyridine manufacturer & supplier

We serve Chemical Name:6-Bromo-3-methoxy-2,4-dimethylpyridine CAS:1062541-77-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

6-Bromo-3-methoxy-2,4-dimethylpyridine

Chemical Name:6-Bromo-3-methoxy-2,4-dimethylpyridine
CAS.NO:1062541-77-8
Synonyms:6-BROMO-3-ISOPROPYL-[1,2,4]TRIAZOLO(4,3-A)PYRIDINE;6-bromo-3-methoxy-2,4-dimethyl-pyridine;2-bromo-5-methoxy-4,6-dimethylpyridine;6-Bromo-3-(propan-2-yl)-[1,2,4]triazolo[4,3-a]pyridine;3-isopropyl-6-bromo-[1,2,4]triazolo(4,3-a)pyridine
Molecular Formula:C8H10BrNO
Molecular Weight:216.07500
HS Code:2933399090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:22.12000
Exact Mass:214.99500
LogP:2.46950

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 6-BROMO-3-ISOPROPYL-[1,2,4]TRIAZOLO(4,3-A)PYRIDINE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-isopropyl-6-bromo-[1,2,4]triazolo(4,3-a)pyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-bromo-5-methoxy-4,6-dimethylpyridine Use and application,6-bromo-3-methoxy-2,4-dimethyl-pyridine technical grade,usp/ep/jp grade.


Related News: According to statistics, in the ten years from 2008 to 2017, a total of 13 China Class 1 small-molecule chemical drugs were independently researched and developed by domestic enterprises in China and approved by the CFDA; in 2018, there were 10 varieties of domestic Class 1 new drugs. Approved for listing in China. 6-Bromo-3-methoxy-2,4-dimethylpyridine manufacturer This time frame optimizes the opportunity to respond to treatment with an HMA prior to declaring treatment failure, as per NCCN Guidelines. Patients are randomized at a 2:1 ratio into two study arms: IV rigosertib plus Best Supportive Care versus Physician��s Choice plus Best Supportive Care. 6-Bromo-3-methoxy-2,4-dimethylpyridine supplier In addition to APIs, a variety of pharmaceutical excipients are contained in the medicine. 6-Bromo-3-methoxy-2,4-dimethylpyridine vendor This time frame optimizes the opportunity to respond to treatment with an HMA prior to declaring treatment failure, as per NCCN Guidelines. Patients are randomized at a 2:1 ratio into two study arms: IV rigosertib plus Best Supportive Care versus Physician��s Choice plus Best Supportive Care. 6-Bromo-3-methoxy-2,4-dimethylpyridine factory According to statistics, in the ten years from 2008 to 2017, a total of 13 China Class 1 small-molecule chemical drugs were independently researched and developed by domestic enterprises in China and approved by the CFDA; in 2018, there were 10 varieties of domestic Class 1 new drugs. Approved for listing in China.